GOLDMAN MYLA LAI Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for GOLDMAN MYLA LAI.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of GOLDMAN MYLA LAI. GOLDMAN MYLA LAI is EVP, Ch. Scien. Off, Med. Dir. in LABORATORY CORP OF AMERICA HOLDINGS ($LH) and EVP, Chf Sci Officer &Med. Dir in LABORATORY CORP OF AMERICA HOLDINGS ($LH) and EVP, Chief Scientific Officer in LABORATORY CORP OF AMERICA HOLDINGS ($LH) and in WEST PHARMACEUTICAL SERVICES INC ($WST) and Director in WEST PHARMACEUTICAL SERVICES INC ($WST) and Director in SEQUENOM INC ($SQNM).
Latest Insider Trading Transactions of GOLDMAN MYLA LAI
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 06 2021 | WST | WEST PHARMACEUTICA ... | LAI GOLDMAN MYLA | Grant | A | 0.00 | 577 | 0 | 16,541 | 16 K to 16.5 K (+3.61 %) | |
May 07 2020 | WST | WEST PHARMACEUTICA ... | LAI GOLDMAN MYLA | Grant | A | 0.00 | 975 | 0 | 15,928 | 15 K to 15.9 K (+6.52 %) | |
May 09 2019 | WST | WEST PHARMACEUTICA ... | LAI GOLDMAN MYLA | Grant | A | 0.00 | 1,565 | 0 | 12,943 | 11.4 K to 12.9 K (+13.75 %) | |
Aug 01 2018 | WST | WEST PHARMACEUTICA ... | LAI GOLDMAN MYLA | Option Exercise | A | 0.00 | 103 | 0 | 1,832 | ||
May 03 2018 | WST | WEST PHARMACEUTICA ... | LAI GOLDMAN MYLA | Grant | A | 0.00 | 1,824 | 0 | 11,378 | 9.6 K to 11.4 K (+19.09 %) | |
Oct 03 2017 | WST | WEST PHARMACEUTICA ... | LAI GOLDMAN MYLA | Option Exercise | A | 0.00 | 104 | 0 | 1,729 | ||
Jul 05 2017 | WST | WEST PHARMACEUTICA ... | LAI GOLDMAN MYLA | Option Exercise | A | 0.00 | 106 | 0 | 1,623 | ||
May 03 2017 | WST | WEST PHARMACEUTICA ... | LAI GOLDMAN MYLA | Grant | A | 0.00 | 1,697 | 0 | 9,529 | 7.8 K to 9.5 K (+21.67 %) | |
Apr 04 2017 | WST | WEST PHARMACEUTICA ... | LAI GOLDMAN MYLA | Option Exercise | A | 0.00 | 122 | 0 | 1,515 | ||
Jan 04 2017 | WST | WEST PHARMACEUTICA ... | LAI GOLDMAN MYLA | Option Exercise | A | 0.00 | 117 | 0 | 1,390 | ||
Oct 04 2016 | WST | WEST PHARMACEUTICA ... | LAI GOLDMAN MYLA | Director | Option Exercise | A | 0.00 | 135 | 0 | 1,269 | |
Sep 07 2016 | SQNM | SEQUENOM INC | LAI GOLDMAN MYLA | Director | Option Exercise | D | 1.11 | 20,000 | 22,200 | 0 | |
Sep 07 2016 | SQNM | SEQUENOM INC | LAI GOLDMAN MYLA | Director | Sell | U | 0.00 | 79,579 | 0 | 0 | 79.6 K to 0 (-100.00 %) |
Jul 05 2016 | WST | WEST PHARMACEUTICA ... | LAI GOLDMAN MYLA | Director | Option Exercise | A | 0.00 | 133 | 0 | 1,134 | |
Jun 16 2016 | SQNM | SEQUENOM INC | LAI GOLDMAN MYLA | Director | Option Exercise | A | 1.11 | 20,000 | 22,200 | 20,000 | |
May 05 2016 | WST | WEST PHARMACEUTICA ... | LAI GOLDMAN MYLA | Director | Grant | A | 0.00 | 2,262 | 0 | 7,785 | 5.5 K to 7.8 K (+40.96 %) |
Apr 04 2016 | WST | WEST PHARMACEUTICA ... | LAI GOLDMAN MYLA | Director | Option Exercise | A | 0.00 | 145 | 0 | 999 | |
Jan 08 2016 | WST | WEST PHARMACEUTICA ... | LAI GOLDMAN MYLA | Director | Option Exercise | A | 0.00 | 143 | 0 | 852 | |
Jan 06 2016 | SQNM | SEQUENOM INC | LAI GOLDMAN MYLA | Director | Grant | A | 0.00 | 31,085 | 0 | 79,579 | 48.5 K to 79.6 K (+64.10 %) |
Oct 05 2015 | WST | WEST PHARMACEUTICA ... | LAI GOLDMAN MYLA | Director | Option Exercise | A | 0.00 | 160 | 0 | 707 | |
Jul 02 2015 | WST | WEST PHARMACEUTICA ... | LAI GOLDMAN MYLA | Director | Option Exercise | A | 0.00 | 237 | 0 | 547 | |
Jun 18 2015 | SQNM | SEQUENOM INC | LAI GOLDMAN MYLA | Director | Option Exercise | A | 3.20 | 20,000 | 64,000 | 20,000 | |
May 07 2015 | WST | WEST PHARMACEUTICA ... | LAI GOLDMAN MYLA | Director | Grant | A | 0.00 | 2,448 | 0 | 5,485 | 3 K to 5.5 K (+80.61 %) |
Apr 02 2015 | WST | WEST PHARMACEUTICA ... | LAI GOLDMAN MYLA | Director | Option Exercise | A | 0.00 | 147 | 0 | 309 | |
Jun 10 2004 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP, Chief Scientif ... | Option Exercise | M | 26.70 | 12,000 | 320,437 | 0 | |
Jun 10 2004 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP, Chief Scientif ... | Sell | S | 42.00 | 12,000 | 504,000 | 52,593 | 64.6 K to 52.6 K (-18.58 %) |
Jun 10 2004 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP, Chief Scientif ... | Buy | M | 26.70 | 12,000 | 320,437 | 64,593 | 52.6 K to 64.6 K (+22.82 %) |
Jun 10 2004 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP, Chief Scientif ... | Option Exercise | M | 26.70 | 12,000 | 320,437 | 0 | |
Jun 10 2004 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP, Chief Scientif ... | Sell | S | 42.00 | 12,000 | 504,000 | 52,593 | 64.6 K to 52.6 K (-18.58 %) |
Jun 10 2004 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP, Chief Scientif ... | Buy | M | 26.70 | 12,000 | 320,437 | 64,593 | 52.6 K to 64.6 K (+22.82 %) |
Apr 23 2004 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP, Chief Scientif ... | Option Exercise | M | 24.46 | 8,250 | 201,795 | 33,960 | |
Apr 23 2004 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP, Chief Scientif ... | Sell | S | 40.00 | 8,250 | 330,000 | 52,593 | 60.8 K to 52.6 K (-13.56 %) |
Apr 23 2004 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP, Chief Scientif ... | Buy | M | 24.46 | 8,250 | 201,795 | 60,843 | 52.6 K to 60.8 K (+15.69 %) |
Apr 22 2004 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP, Chief Scientif ... | Option Exercise | M | 24.46 | 4,922 | 120,392 | 41,850 | |
Apr 22 2004 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP, Chief Scientif ... | Sell | S | 40.00 | 693 | 27,720 | 52,593 | 53.3 K to 52.6 K (-1.30 %) |
Apr 22 2004 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP, Chief Scientif ... | Sell | S | 40.02 | 693 | 27,734 | 53,286 | 54 K to 53.3 K (-1.28 %) |
Apr 22 2004 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP, Chief Scientif ... | Sell | S | 40.05 | 589 | 23,589 | 53,979 | 54.6 K to 54 K (-1.08 %) |
Apr 22 2004 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP, Chief Scientif ... | Sell | S | 40.07 | 693 | 27,769 | 54,568 | 55.3 K to 54.6 K (-1.25 %) |
Apr 22 2004 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP, Chief Scientif ... | Sell | S | 40.10 | 694 | 27,829 | 55,261 | 56 K to 55.3 K (-1.24 %) |
Apr 22 2004 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP, Chief Scientif ... | Sell | S | 40.12 | 693 | 27,803 | 55,955 | 56.6 K to 56 K (-1.22 %) |
Apr 22 2004 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP, Chief Scientif ... | Sell | S | 40.16 | 867 | 34,819 | 56,648 | 57.5 K to 56.6 K (-1.51 %) |
Apr 22 2004 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP, Chief Scientif ... | Buy | M | 24.46 | 4,922 | 120,392 | 57,515 | 52.6 K to 57.5 K (+9.36 %) |
Apr 15 2004 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP, Chief Scientif ... | Option Exercise | M | 24.46 | 3,628 | 88,741 | 46,772 | |
Apr 15 2004 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP, Chief Scientif ... | Sell | S | 40.00 | 1,375 | 55,000 | 52,593 | 54 K to 52.6 K (-2.55 %) |
Apr 15 2004 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP, Chief Scientif ... | Sell | S | 40.02 | 1,560 | 62,431 | 53,968 | 55.5 K to 54 K (-2.81 %) |
Apr 15 2004 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP, Chief Scientif ... | Sell | S | 40.06 | 693 | 27,762 | 55,528 | 56.2 K to 55.5 K (-1.23 %) |
Apr 15 2004 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP, Chief Scientif ... | Buy | M | 24.46 | 3,628 | 88,741 | 56,221 | 52.6 K to 56.2 K (+6.90 %) |
Mar 18 2004 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP, Chief Scientif ... | Sell | S | 37.50 | 583 | 21,863 | 52,593 | 53.2 K to 52.6 K (-1.10 %) |
Mar 18 2004 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP, Chief Scientif ... | Sell | S | 37.51 | 91 | 3,413 | 53,176 | 53.3 K to 53.2 K (-0.17 %) |
Mar 18 2004 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP, Chief Scientif ... | Sell | S | 37.52 | 149 | 5,590 | 53,267 | 53.4 K to 53.3 K (-0.28 %) |
Mar 18 2004 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP, Chief Scientif ... | Sell | S | 37.53 | 1,007 | 37,793 | 53,416 | 54.4 K to 53.4 K (-1.85 %) |
Mar 18 2004 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP, Chief Scientif ... | Sell | S | 37.54 | 114 | 4,280 | 54,423 | 54.5 K to 54.4 K (-0.21 %) |
Mar 18 2004 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP, Chief Scientif ... | Sell | S | 37.55 | 663 | 24,896 | 54,537 | 55.2 K to 54.5 K (-1.20 %) |
Mar 18 2004 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP, Chief Scientif ... | Sell | S | 37.56 | 355 | 13,334 | 55,200 | 55.6 K to 55.2 K (-0.64 %) |
Mar 18 2004 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP, Chief Scientif ... | Sell | S | 37.57 | 173 | 6,500 | 55,555 | 55.7 K to 55.6 K (-0.31 %) |
Mar 18 2004 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP, Chief Scientif ... | Sell | S | 37.58 | 46 | 1,729 | 55,728 | 55.8 K to 55.7 K (-0.08 %) |
Mar 18 2004 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP, Chief Scientif ... | Sell | S | 37.59 | 57 | 2,143 | 55,774 | 55.8 K to 55.8 K (-0.10 %) |
Mar 18 2004 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP, Chief Scientif ... | Sell | S | 37.60 | 91 | 3,422 | 55,831 | 55.9 K to 55.8 K (-0.16 %) |
Mar 18 2004 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP, Chief Scientif ... | Sell | S | 37.62 | 46 | 1,731 | 55,922 | 56 K to 55.9 K (-0.08 %) |
Mar 18 2004 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP, Chief Scientif ... | Sell | S | 37.63 | 57 | 2,145 | 55,968 | 56 K to 56 K (-0.10 %) |
Mar 18 2004 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP, Chief Scientif ... | Sell | S | 37.64 | 34 | 1,280 | 56,025 | 56.1 K to 56 K (-0.06 %) |
Mar 18 2004 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP, Chief Scientif ... | Sell | S | 37.65 | 34 | 1,280 | 56,059 | 56.1 K to 56.1 K (-0.06 %) |
Mar 18 2004 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP, Chief Scientif ... | Sell | S | 37.66 | 114 | 4,293 | 56,093 | 56.2 K to 56.1 K (-0.20 %) |
Mar 18 2004 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP, Chief Scientif ... | Sell | S | 37.67 | 91 | 3,428 | 56,207 | 56.3 K to 56.2 K (-0.16 %) |
Mar 18 2004 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP, Chief Scientif ... | Sell | S | 37.68 | 69 | 2,600 | 56,298 | 56.4 K to 56.3 K (-0.12 %) |
Mar 18 2004 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP, Chief Scientif ... | Sell | S | 37.69 | 217 | 8,179 | 56,367 | 56.6 K to 56.4 K (-0.38 %) |
Mar 18 2004 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP, Chief Scientif ... | Sell | S | 37.70 | 194 | 7,314 | 56,584 | 56.8 K to 56.6 K (-0.34 %) |
Mar 18 2004 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP, Chief Scientif ... | Sell | S | 37.71 | 56 | 2,112 | 56,778 | 56.8 K to 56.8 K (-0.10 %) |
Mar 18 2004 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP, Chief Scientif ... | Sell | S | 37.72 | 58 | 2,188 | 56,834 | 56.9 K to 56.8 K (-0.10 %) |
Mar 18 2004 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP, Chief Scientif ... | Sell | S | 37.73 | 277 | 10,451 | 56,892 | 57.2 K to 56.9 K (-0.48 %) |
Mar 18 2004 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP, Chief Scientif ... | Sell | S | 37.74 | 172 | 6,491 | 57,169 | 57.3 K to 57.2 K (-0.30 %) |
Mar 18 2004 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP, Chief Scientif ... | Sell | S | 37.76 | 9 | 340 | 57,341 | 57.4 K to 57.3 K (-0.02 %) |
Mar 18 2004 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP, Chief Scientif ... | Sell | S | 37.80 | 69 | 2,608 | 57,350 | 57.4 K to 57.4 K (-0.12 %) |
Mar 18 2004 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP, Chief Scientif ... | Sell | S | 37.87 | 69 | 2,613 | 57,419 | 57.5 K to 57.4 K (-0.12 %) |
Mar 18 2004 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP, Chief Scientif ... | Sell | S | 37.90 | 399 | 15,122 | 57,488 | 57.9 K to 57.5 K (-0.69 %) |
Mar 18 2004 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP, Chief Scientif ... | Sell | S | 37.91 | 23 | 872 | 57,887 | 57.9 K to 57.9 K (-0.04 %) |
Mar 18 2004 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP, Chief Scientif ... | Sell | S | 37.95 | 263 | 9,981 | 57,910 | 58.2 K to 57.9 K (-0.45 %) |
Mar 18 2004 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP, Chief Scientif ... | Sell | S | 38.00 | 194 | 7,372 | 58,173 | 58.4 K to 58.2 K (-0.33 %) |
Mar 18 2004 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP, Chief Scientif ... | Sell | S | 38.01 | 103 | 3,915 | 58,367 | 58.5 K to 58.4 K (-0.18 %) |
Mar 18 2004 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP, Chief Scientif ... | Sell | S | 38.07 | 35 | 1,332 | 58,470 | 58.5 K to 58.5 K (-0.06 %) |
Mar 18 2004 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP, Chief Scientif ... | Sell | S | 38.10 | 103 | 3,924 | 58,505 | 58.6 K to 58.5 K (-0.18 %) |
Mar 17 2004 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP, Chief Scientif ... | Sell | S | 37.90 | 10,335 | 391,697 | 58,608 | 68.9 K to 58.6 K (-14.99 %) |
Mar 17 2004 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP, Chief Scientif ... | Sell | S | 37.91 | 525 | 19,903 | 66,943 | 67.5 K to 66.9 K (-0.78 %) |
Mar 17 2004 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP, Chief Scientif ... | Sell | S | 37.92 | 324 | 12,286 | 67,468 | 67.8 K to 67.5 K (-0.48 %) |
Mar 17 2004 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP, Chief Scientif ... | Sell | S | 37.93 | 103 | 3,907 | 67,792 | 67.9 K to 67.8 K (-0.15 %) |
Mar 17 2004 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP, Chief Scientif ... | Sell | S | 37.94 | 149 | 5,653 | 67,895 | 68 K to 67.9 K (-0.22 %) |
Mar 17 2004 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP, Chief Scientif ... | Sell | S | 37.95 | 917 | 34,800 | 68,044 | 69 K to 68 K (-1.33 %) |
Mar 17 2004 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP, Chief Scientif ... | Sell | S | 37.96 | 378 | 14,349 | 68,961 | 69.3 K to 69 K (-0.55 %) |
Mar 17 2004 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP, Chief Scientif ... | Sell | S | 37.97 | 252 | 9,568 | 69,339 | 69.6 K to 69.3 K (-0.36 %) |
Mar 17 2004 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP, Chief Scientif ... | Sell | S | 37.98 | 407 | 15,458 | 69,591 | 70 K to 69.6 K (-0.58 %) |
Mar 17 2004 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP, Chief Scientif ... | Sell | S | 37.99 | 123 | 4,673 | 69,998 | 70.1 K to 70 K (-0.18 %) |
Mar 17 2004 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP, Chief Scientif ... | Sell | S | 38.00 | 538 | 20,444 | 70,121 | 70.7 K to 70.1 K (-0.76 %) |
Mar 17 2004 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP, Chief Scientif ... | Sell | S | 38.01 | 34 | 1,292 | 70,659 | 70.7 K to 70.7 K (-0.05 %) |
Mar 17 2004 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP, Chief Scientif ... | Sell | S | 38.02 | 34 | 1,293 | 70,693 | 70.7 K to 70.7 K (-0.05 %) |
Mar 17 2004 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP, Chief Scientif ... | Sell | S | 38.03 | 186 | 7,074 | 70,727 | 70.9 K to 70.7 K (-0.26 %) |
Mar 17 2004 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP, Chief Scientif ... | Sell | S | 38.04 | 391 | 14,874 | 70,913 | 71.3 K to 70.9 K (-0.55 %) |
Mar 17 2004 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP, Chief Scientif ... | Sell | S | 38.05 | 134 | 5,099 | 71,304 | 71.4 K to 71.3 K (-0.19 %) |
Mar 17 2004 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP, Chief Scientif ... | Sell | S | 38.06 | 46 | 1,751 | 71,438 | 71.5 K to 71.4 K (-0.06 %) |
Mar 17 2004 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP, Chief Scientif ... | Sell | S | 38.07 | 103 | 3,921 | 71,484 | 71.6 K to 71.5 K (-0.14 %) |
Mar 17 2004 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP, Chief Scientif ... | Sell | S | 38.08 | 11 | 419 | 71,587 | 71.6 K to 71.6 K (-0.02 %) |
Mar 17 2004 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP, Chief Scientif ... | Sell | S | 38.09 | 240 | 9,142 | 71,598 | 71.8 K to 71.6 K (-0.33 %) |
Mar 17 2004 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP, Chief Scientif ... | Sell | S | 38.10 | 80 | 3,048 | 71,838 | 71.9 K to 71.8 K (-0.11 %) |
Mar 17 2004 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP, Chief Scientif ... | Sell | S | 38.11 | 77 | 2,934 | 71,918 | 72 K to 71.9 K (-0.11 %) |
Mar 17 2004 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP, Chief Scientif ... | Sell | S | 38.12 | 3 | 114 | 71,995 | 72 K to 72 K (0.00 %) |
Mar 17 2004 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP, Chief Scientif ... | Sell | S | 38.13 | 91 | 3,470 | 71,998 | 72.1 K to 72 K (-0.13 %) |
Mar 17 2004 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP, Chief Scientif ... | Payment of Exercise | F | 38.05 | 10,325 | 392,866 | 72,089 | 82.4 K to 72.1 K (-12.53 %) |
Feb 19 2004 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP, Chf Sci Office ... | Option Exercise | A | 39.00 | 50,400 | 1,965,600 | 50,400 | |
Nov 03 2003 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP, Ch. Scien. Off ... | Option Exercise | M | 10.31 | 14,800 | 152,625 | 0 | |
Nov 03 2003 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP, Ch. Scien. Off ... | Sell | S | 35.60 | 851 | 30,296 | 84,062 | 84.9 K to 84.1 K (-1.00 %) |
Nov 03 2003 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP, Ch. Scien. Off ... | Sell | S | 35.40 | 851 | 30,125 | 84,913 | 85.8 K to 84.9 K (-0.99 %) |
Nov 03 2003 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP, Ch. Scien. Off ... | Sell | S | 35.35 | 2,849 | 100,712 | 85,764 | 88.6 K to 85.8 K (-3.22 %) |
Nov 03 2003 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP, Ch. Scien. Off ... | Sell | S | 35.30 | 553 | 19,521 | 88,613 | 89.2 K to 88.6 K (-0.62 %) |
Nov 03 2003 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP, Ch. Scien. Off ... | Sell | S | 35.25 | 850 | 29,963 | 89,166 | 90 K to 89.2 K (-0.94 %) |
Nov 03 2003 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP, Ch. Scien. Off ... | Sell | S | 35.20 | 2,126 | 74,835 | 90,016 | 92.1 K to 90 K (-2.31 %) |
Nov 03 2003 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP, Ch. Scien. Off ... | Sell | S | 35.16 | 1,616 | 56,819 | 92,142 | 93.8 K to 92.1 K (-1.72 %) |
Nov 03 2003 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP, Ch. Scien. Off ... | Sell | S | 35.15 | 851 | 29,913 | 93,758 | 94.6 K to 93.8 K (-0.90 %) |
Nov 03 2003 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP, Ch. Scien. Off ... | Sell | S | 35.12 | 1,276 | 44,813 | 94,609 | 95.9 K to 94.6 K (-1.33 %) |
Nov 03 2003 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP, Ch. Scien. Off ... | Sell | S | 35.11 | 851 | 29,879 | 95,885 | 96.7 K to 95.9 K (-0.88 %) |
Nov 03 2003 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP, Ch. Scien. Off ... | Sell | S | 35.10 | 2,126 | 74,623 | 96,736 | 98.9 K to 96.7 K (-2.15 %) |
Nov 03 2003 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP, Ch. Scien. Off ... | Buy | M | 10.31 | 14,800 | 152,625 | 98,862 | 84.1 K to 98.9 K (+17.61 %) |
Nov 03 2003 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP, Ch. Scien. Off ... | Option Exercise | M | 10.31 | 14,800 | 152,625 | 0 | |
Nov 03 2003 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP, Ch. Scien. Off ... | Sell | S | 35.60 | 851 | 30,296 | 84,062 | 84.9 K to 84.1 K (-1.00 %) |
Nov 03 2003 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP, Ch. Scien. Off ... | Sell | S | 35.40 | 851 | 30,125 | 84,913 | 85.8 K to 84.9 K (-0.99 %) |
Nov 03 2003 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP, Ch. Scien. Off ... | Sell | S | 35.35 | 2,849 | 100,712 | 85,764 | 88.6 K to 85.8 K (-3.22 %) |
Nov 03 2003 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP, Ch. Scien. Off ... | Sell | S | 35.30 | 553 | 19,521 | 88,613 | 89.2 K to 88.6 K (-0.62 %) |
Nov 03 2003 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP, Ch. Scien. Off ... | Sell | S | 35.25 | 850 | 29,963 | 89,166 | 90 K to 89.2 K (-0.94 %) |
Nov 03 2003 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP, Ch. Scien. Off ... | Sell | S | 35.20 | 2,126 | 74,835 | 90,016 | 92.1 K to 90 K (-2.31 %) |
Nov 03 2003 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP, Ch. Scien. Off ... | Sell | S | 35.16 | 1,616 | 56,819 | 92,142 | 93.8 K to 92.1 K (-1.72 %) |
Nov 03 2003 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP, Ch. Scien. Off ... | Sell | S | 35.15 | 851 | 29,913 | 93,758 | 94.6 K to 93.8 K (-0.90 %) |
Nov 03 2003 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP, Ch. Scien. Off ... | Sell | S | 35.12 | 1,276 | 44,813 | 94,609 | 95.9 K to 94.6 K (-1.33 %) |
Nov 03 2003 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP, Ch. Scien. Off ... | Sell | S | 35.11 | 851 | 29,879 | 95,885 | 96.7 K to 95.9 K (-0.88 %) |
Nov 03 2003 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP, Ch. Scien. Off ... | Sell | S | 35.10 | 2,126 | 74,623 | 96,736 | 98.9 K to 96.7 K (-2.15 %) |
Nov 03 2003 | LH | LABORATORY CORP OF ... | LAI GOLDMAN MYLA | EVP, Ch. Scien. Off ... | Buy | M | 10.31 | 14,800 | 152,625 | 98,862 | 84.1 K to 98.9 K (+17.61 %) |
Page: 1